Thyroid C-cell Tumors: In rodent reports, semaglutide is proven to trigger thyroid C-mobile tumors. It's unknown no matter whether this chance relates to humans, but semaglutide is contraindicated in clients with a personal or family members background of medullary thyroid carcinoma (MTC) or clients with Many Endocrine Neoplasia syndrome form two (